FSNU.F Stock Overview
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Fresenius SE & Co. KGaA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €26.65 |
| 52 Week High | €32.43 |
| 52 Week Low | €25.77 |
| Beta | 1.08 |
| 1 Month Change | -4.51% |
| 3 Month Change | -6.57% |
| 1 Year Change | -3.86% |
| 3 Year Change | -42.33% |
| 5 Year Change | -51.01% |
| Change since IPO | -84.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| FSNU.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -4.5% | 2.1% | 1.2% |
| 1Y | -3.9% | 3.6% | 24.7% |
Return vs Industry: FSNU.F underperformed the US Healthcare industry which returned 4% over the past year.
Return vs Market: FSNU.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| FSNU.F volatility | |
|---|---|
| FSNU.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FSNU.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine FSNU.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1912 | 193,865 | Michael Sen | www.fresenius.com |
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Fresenius SE & Co. KGaA Fundamentals Summary
| FSNU.F fundamental statistics | |
|---|---|
| Market cap | US$16.66b |
| Earnings (TTM) | US$377.54m |
| Revenue (TTM) | US$23.85b |
43.7x
P/E Ratio0.7x
P/S RatioIs FSNU.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FSNU.F income statement (TTM) | |
|---|---|
| Revenue | €22.30b |
| Cost of Revenue | €17.24b |
| Gross Profit | €5.06b |
| Other Expenses | €4.71b |
| Earnings | €353.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | 0.63 |
| Gross Margin | 22.68% |
| Net Profit Margin | 1.58% |
| Debt/Equity Ratio | 70.4% |
How did FSNU.F perform over the long term?
See historical performance and comparison